Structure |
Chemical Name |
CAS |
MF |
|
N-(2-Chloropyrimidin-4-YL)-2,3-dimethyl-2H-indazol-6-amine |
444731-74-2 |
C13H12ClN5 |
|
Vonoprazan fumarate |
1260141-27-2 |
C21H20FN3O6S |
|
6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
1016636-76-2 |
C13H13BrClN3O |
|
Trelagliptin succinate |
1029877-94-8 |
C22H26FN5O6 |
|
2,2',7,7'-Tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene |
207739-72-8 |
C81H68N4O8 |
|
5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester |
70374-38-8 |
C10H12ClNO6S2 |
|
(6R,S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN DIHYDROCHLORIDE |
62989-33-7 |
C9H15N5O3 |
|
1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE |
18048-64-1 |
C12H14N2O |
|
ledipasvir interMediate |
1441673-92-2 |
C12H20KNO4 |
|
4-Benzofurancarboxylic Acid |
166599-84-4 |
C9H6O3 |
|
Methyl 5-chloro-3-chlorosulfonyl-2-thiophene carboxylate |
70374-37-7 |
C7H8ClNO4S2 |
|
2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid |
70785-61-4 |
C15H14N2O5 |
|
2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one |
277299-70-4 |
C12H14N2O |
|
3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine |
134002-25-8 |
C18H20N2O |
|
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
477600-70-7 |
C14H22N2 |
|
2'-Bromo-2'-deoxyuridine |
72218-68-9 |
C9H11BrN2O5 |
|
Itraconzole intermediate |
|
|
|
(2R,3R,4R,5R)-4-(Acetyloxy)-2-(5-fluoro-4-formamido-2-oxo-1,2-dihydropyrimidin-1-yl)-5-methyloxolan-3-yl acetate |
|
|
|
cytidylyl-(5'->3')-guanosine |
4785-04-0 |
C19H25N8O12P |
|
(6R-trans)-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
58233-18-4 |
C15H16N4O6S2 |
|
4-(dimethylammonio)piperidinium dichloride |
4876-59-9 |
C7H18Cl2N2 |
|
tert-Butyl (1-(hydroxymethyl)cyclopropyl)carbamate |
107017-73-2 |
C9H17NO3 |
|
1-Methyl-3-pyrrolidinol |
13220-33-2 |
C5H11NO |
|
5,6,12,13-tetrabromo-Perylo[3,4-cd:9,10-c'd']dipyran-1,3,8,10-tetrone |
321945-85-1 |
C24H4Br4O6 |
|
Ofloxacin EP Impurity C |
95848-94-5 |
C18H21N3O4 |
|
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate |
1034975-62-6 |
C21H25F6N3O6 |
|
Posaconazole Diastereoisomer 11 |
171228-50-5 |
C37H42F2N8O4 |
|
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
941688-05-7 |
C17H18N6 |
|
Eribulin intermediate |
157322-47-9 |
C21H35IO4 |
|
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
1428243-26-8 |
C16H20BrNO3 |
|
tiotropium bromide hydrate |
411207-31-3 |
C19H24BrNO5S2 |
|
Azacitidine Impurity 3 |
157771-77-2 |
C8H12N4O5 |
|
Lumacaftor Intermediate |
936727-68-3 |
C17H13ClF2N2O3 |
|
3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene |
54690-63-0 |
C24H35NO3Si |
|
Dehydronandrolone Acetate |
2590-41-2 |
C20H26O3 |
|
(4-bromo-2-fluorophenyl)-(3,4,5-trimethoxyphenyl)methanone |
1016544-26-5 |
C16H14BrFO4 |
|
16,16-DIMETHYL PROSTAGLANDIN E2 |
39746-25-3 |
C22H36O5 |
|
9-Phenylacridine |
602-56-2 |
C19H13N |
|
6R,7S-Ceftazidime isomer |
|
|
|
Oseltamivir Fructose Adduct 2 |
|
|
|
Sugammadex sodium Pentabromide intermediate |
|
|
|
(3S,5S,2S,3R)-posaconazole |
|
|
|
tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate |
1350636-75-7 |
C11H21NO3S |
|
Isopropyl creatinine |
|
C7H13N3O |
|
2-(4-NITROPHENYL)BUTYRIC ACID |
7463-53-8 |
C10H11NO4 |
|
Ceftiofur Double Side Chain |
|
|
|
Flomoxef Intermediate F3-01 |
|
|
|
5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo- |
1985668-78-7 |
C27H30N4O2 |
|
2',3'-Dideoxy-2',3'-didehydroinosine |
42867-68-5 |
C10H10N4O3 |
|
Cephalosporin |
11111-12-9 |
C16H21N3O8S |
|
3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-one |
15462-91-6 |
C22H26O6 |
|
potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate |
5991-71-9 |
C16H10ClKN2O3 |
|
hexahydro-1-methyl-3-(3-oxo-1-cyclohexen-1-yl)-2H-azepin-2-one |
71556-70-2 |
C13H19NO2 |
|
alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylphenethyl alcohol |
73404-00-9 |
C26H31NO2 |
|
Engelide intermediate |
|
|
|
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate |
154330-68-4 |
C16H15F2NO4S |
|
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride |
1373116-04-1 |
C25H37ClF2N2OSi |
|
Cefiderocol |
1225208-94-5 |
C30H34ClN7O10S2 |
|
2,3-Dimethylbenzyl alcohol |
13651-14-4 |
C9H12O |
|
(1R)-(+)-TRANS-PINANE |
4863-59-6 |
C10H18 |
|
5-Methyl-4-isoxazolecarboxylic acid |
42831-50-5 |
C5H5NO3 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN E2 |
363-23-5 |
C20H32O5 |
|
L-(+)-Ergothioneine |
497-30-3 |
C9H15N3O2S |
|
Material intermediate |
162039-67-0 |
C18H14N4 |
|
(3-BROMOACETYL)COUMARIN |
29310-88-1 |
C11H7BrO3 |
|
Primary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
Sugammadex sodium Heptabromide intermediate |
|
|
|
Rabacfosadine succinate |
1431856-99-3 |
C25H41N8O10P |
|
Cefotiam (6R,7S) isomer reference |
|
|
|
Ceftiofur Double Mother Nucleus |
|
|
|
7S-Cephalexin |
|
|
|
(6R,7S)-Latamoxef MotherNucleus |
|
|
|
COUMARIN 6 |
88241-65-0 |
C15H12O2 |
|
FLUTICASONE PROPIONATE INTERMEDIATE |
80474-45-9 |
C24H30F2O5S |
|
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
|
1,3-Benzodioxole-5-acetic acid methyl ester |
326-59-0 |
C10H10O4 |
|
Dolutegravir intermediate |
|
|
|
(7S)-Cefuroxime |
|
|
|
5-phenyl-2,3,7-tris(phenylamino)phenazinium chloride |
4935-81-3 |
C36H28ClN5 |
|
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-3,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,3R)- |
2209874-09-7 |
C12H20N2O3 |
|
6-METHYLENEANDROST-4-ENE-3,17-DIONE |
19457-55-7 |
C20H26O2 |
|
Prostaglandin F3a |
|
|
|
8-iso Prostaglandin F2a-d4 |
|
|
|
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN |
82747-36-2 |
C10H5F3O4 |
|
455284-06-7 |
455284-06-7 |
|
|
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
|
4-Chlorodehydromethyltestosterone |
2446-23-3 |
C20H27ClO2 |
|
2'-iodo-2'-deoxyuridine |
4753-03-1 |
C9H11IN2O5 |
|
(1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane |
110567-22-1 |
C20H22O3 |
|
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
|
(+)-Camphor Bromide |
10293-06-8 |
C10H15BrO |
|
Perfluoro(4-methyl-3,6-dioxaoct-7-ene)sulfonyl fluoride |
16090-14-5 |
C7F14O4S |
|
7-METHOXY-4-(TRIFLUOROMETHYL)COUMARIN |
575-04-2 |
C11H7F3O3 |
|
Tert-Butyl 4-Vinylphenyl Carbonate |
87188-51-0 |
C13H16O3 |
|
4-[3-(Trifluoromethyl)phenyl]-1-piperazineethanol |
40004-29-3 |
C13H17F3N2O |
|
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
446292-08-6 |
C22H19N3O6 |
|
Orlistat pellets |
|
|
|
3-Des(1-ethylpropoxy)-3-(1-Methylpropoxy) OseltaMivir |
1052063-37-2 |
C15H26N2O4 |
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
1334513-02-8 |
C18H17F5NO5P |
|
isopropylideneaMinooxyethanol |
83495-51-6 |
C5H11NO2 |